The purpose of this study is to determine if oral mucosal application of chlorhexidine gel will prevent the development of ventilator associated pneumonia in children.
Ventilator associated pneumonia as the name suggests refers to pneumonia occurring in the setting of mechanical ventilation. It accounts of 86% of nosocomial pneumonia and in contrast to other more common nosocomial infections is accompanied by a mortality rate of upto 76% in certain settings. A number of preventive methods have been studied to reduce the rate of VAP but a consensus is lacking with regards to appropriate preventive strategies. Studies in adults have shown a beneficial effect of oral mucosal application of chlorhexidine but similar studies in pediatric population are not available. This research project aims at addressing the gap.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
86
Oral mucosal application of chlorhexidine gel
Oral mucosal application of placebo gel
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
Occurrence of ventilator associated pneumonia as defined by CDC diagnostic criteria
Time frame: 21 days
Antibiotic sensitivity of organism cultured
Time frame: 21 days
Duration of hospital stay
Time frame: 21 days
Duration of ICU stay
Time frame: 21 days
In hospital mortality rate
Time frame: 21 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.